Free Trial

vTv Therapeutics (VTVT) Competitors

vTv Therapeutics logo
$16.21 -0.56 (-3.32%)
Closing price 03:59 PM Eastern
Extended Trading
$16.49 +0.28 (+1.70%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VTVT vs. CRGX, NLTX, ACIU, LRMR, CGC, FDMT, YMAB, OGI, ENGN, and RAPT

Should you be buying vTv Therapeutics stock or one of its competitors? The main competitors of vTv Therapeutics include CARGO Therapeutics (CRGX), Neoleukin Therapeutics (NLTX), AC Immune (ACIU), Larimar Therapeutics (LRMR), Canopy Growth (CGC), 4D Molecular Therapeutics (FDMT), Y-mAbs Therapeutics (YMAB), Organigram Global (OGI), enGene (ENGN), and Rapt Therapeutics (RAPT). These companies are all part of the "pharmaceutical products" industry.

vTv Therapeutics vs. Its Competitors

CARGO Therapeutics (NASDAQ:CRGX) and vTv Therapeutics (NASDAQ:VTVT) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, dividends, profitability, valuation, earnings, risk and institutional ownership.

CARGO Therapeutics has a beta of 0.28, indicating that its share price is 72% less volatile than the S&P 500. Comparatively, vTv Therapeutics has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500.

In the previous week, CARGO Therapeutics had 1 more articles in the media than vTv Therapeutics. MarketBeat recorded 2 mentions for CARGO Therapeutics and 1 mentions for vTv Therapeutics. vTv Therapeutics' average media sentiment score of 1.16 beat CARGO Therapeutics' score of 0.00 indicating that vTv Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
CARGO Therapeutics Neutral
vTv Therapeutics Positive

CARGO Therapeutics presently has a consensus price target of $15.40, indicating a potential upside of 240.71%. vTv Therapeutics has a consensus price target of $35.50, indicating a potential upside of 118.96%. Given CARGO Therapeutics' higher possible upside, equities analysts clearly believe CARGO Therapeutics is more favorable than vTv Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CARGO Therapeutics
1 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.86
vTv Therapeutics
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

vTv Therapeutics has higher revenue and earnings than CARGO Therapeutics. vTv Therapeutics is trading at a lower price-to-earnings ratio than CARGO Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CARGO TherapeuticsN/AN/A-$167.50M-$4.62-0.98
vTv Therapeutics$1.02M50.71-$18.46M-$3.01-5.39

CARGO Therapeutics' return on equity of -45.93% beat vTv Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
CARGO TherapeuticsN/A -45.93% -39.58%
vTv Therapeutics N/A -121.46%-46.75%

93.2% of CARGO Therapeutics shares are held by institutional investors. Comparatively, 17.5% of vTv Therapeutics shares are held by institutional investors. 2.9% of CARGO Therapeutics shares are held by company insiders. Comparatively, 4.2% of vTv Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

vTv Therapeutics beats CARGO Therapeutics on 8 of the 14 factors compared between the two stocks.

Get vTv Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for VTVT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VTVT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VTVT vs. The Competition

MetricvTv TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$51.72M$3.06B$5.67B$9.49B
Dividend YieldN/A2.44%4.05%4.00%
P/E Ratio-5.3920.8627.9419.95
Price / Sales50.71246.06396.5882.68
Price / CashN/A41.9636.1958.45
Price / Book3.628.308.635.82
Net Income-$18.46M-$55.19M$3.24B$258.42M
7 Day Performance0.33%5.07%3.22%1.94%
1 Month Performance2.61%17.61%10.72%12.02%
1 Year Performance-31.59%7.03%34.94%20.80%

vTv Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VTVT
vTv Therapeutics
1.5928 of 5 stars
$16.21
-3.3%
$35.50
+119.0%
-31.7%$51.72M$1.02M-5.399Positive News
CRGX
CARGO Therapeutics
1.6492 of 5 stars
$4.52
-1.1%
$15.40
+240.7%
-74.4%$210.72MN/A-0.98116High Trading Volume
NLTX
Neoleukin Therapeutics
N/A$22.34
-1.2%
N/A-48.1%$209.95MN/A-7.1890News Coverage
Gap Up
High Trading Volume
ACIU
AC Immune
1.4385 of 5 stars
$2.08
+0.5%
$12.00
+476.9%
-36.6%$207.85M$31.02M-3.59140Positive News
LRMR
Larimar Therapeutics
1.7589 of 5 stars
$3.26
+1.6%
$18.50
+467.5%
-60.1%$205.53MN/A-2.1930
CGC
Canopy Growth
0.4482 of 5 stars
$1.12
+2.8%
N/A-85.7%$200.41M$225.65M-0.283,150
FDMT
4D Molecular Therapeutics
2.2945 of 5 stars
$4.24
+0.5%
$29.56
+597.1%
-73.7%$195.49M$40K-1.33120News Coverage
YMAB
Y-mAbs Therapeutics
3.1287 of 5 stars
$4.33
+0.5%
$15.60
+260.3%
-62.5%$195.17M$87.68M-6.77150News Coverage
Positive News
OGI
Organigram Global
0.663 of 5 stars
$1.46
+0.7%
N/A-11.7%$194.21M$117.47M14.60860
ENGN
enGene
2.9232 of 5 stars
$3.85
+1.6%
$23.29
+504.8%
-56.1%$193.69MN/A-2.3331
RAPT
Rapt Therapeutics
4.3365 of 5 stars
$11.70
+0.2%
$19.80
+69.2%
-42.9%$193.14M$1.53M-0.6180News Coverage
Analyst Upgrade

Related Companies and Tools


This page (NASDAQ:VTVT) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners